Currently out of the existing stock ratings of Alex Thompson, 110 are a BUY (83.33%), 22 are a HOLD (16.67%).

Alex Thompson

Work Performance Price Targets & Ratings Chart

Analyst Alex Thompson, currently employed at STIFEL, carries an average stock price target met ratio of 64.32% that have a potential upside of 68.8% achieved within 177 days.

Alex Thompson’s has documented 247 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on KYMR, Kymera Therapeutics at 22-Sep-2026.

Wall Street Analyst Alex Thompson

Analyst best performing recommendations are on DICE (DICE MOLECULES HOLDINGS LLC).
The best stock recommendation documented was for DICE (DICE MOLECULES HOLDINGS LLC) at 9/6/2022. The price target of $37 was fulfilled within 35 days with a profit of $18.05 (95.25%) receiving and performance score of 27.21.

Average potential price target upside

DICE Dice Molecules Holdings LLC VTYX Ventyx Biosciences ARGX argenx NV ADR ACRS Aclaris Therapeutics MORF Morphic PLRX Pliant Therapeutics TVTX Travere Therapeutics KDNY Chinook Therapeutics IMVT Immunovant MLTX MoonLake Immunotherapeutics VRDN Viridian Therapeutics AGLE Aeglea Bio Therapeutics ASND Ascendis Pharma AS APGE Apogee Therapeutics, Common Stock SYRE Spyre Therapeutics ANAB AnaptysBio CRNX Crinetics Pharmaceuticals KYMR Kymera Therapeutics AVTX Avalo Therapeutics CLDX Celldex Therapeutics DNTH Dianthus Therapeutics ORKA Oruka Therapeutics RAPT RAPT Therapeutics THRD Third Harmonic Bio

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 09-Aug-2023

$48

$0.45 (0.95%)

$48

3 years 1 months 21 days ago
(09-Aug-2023)

1/8 (12.5%)

$0.45 (0.95%)

85

Hold Since 26-Jun-2023

$56

3 years 3 months 4 days ago
(26-Jun-2023)

0/1 (0%)

$27.35 (95.46%)

Buy Since 22-May-2023

$48

3 years 3 months 9 days ago
(21-Jun-2023)

0/2 (0%)

$1.56 (3.36%)

Buy Since 14-Sep-2022

$48

$0.45 (0.95%)

$68

3 years 3 months 10 days ago
(20-Jun-2023)

1/3 (33.33%)

$1.56 (3.36%)

27

Hold Since 24-May-2023

$48

$0.45 (0.95%)

$38

3 years 3 months 10 days ago
(20-Jun-2023)

1/2 (50%)

$1.56 (3.36%)

27

Show more analysts

Please expand the browser size to see the chart

Which stock is Alex Thompson most bullish on?

Potential upside of $100.4 has been obtained for ASND (ASCENDIS PHARMA AS)

Which stock is Alex Thompson most reserved on?

Potential downside of $21.31 has been obtained for SYRE (SPYRE THERAPEUTICS)

What Year was the first public recommendation made by Alex Thompson?

On 2022
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?